1404480-11-0Relevant articles and documents
Enhanced treatment regimens using mTor inhibitors
-
, (2015/11/27)
The present invention provides for methods and pharmaceutical compositions comprising inhibitors of mTorC1 and/or mTorC2. In some aspects, the invention provides for treatment regimens resulting in enhanced treatment efficacy and better tolerability.
COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
-
, (2014/12/09)
The present invention provides for methods and pharmaceutical compositions for treating proliferative disorders. In one aspect, the method comprises administration of two cell-cycle suppressors having a synergistic effect. In another aspect, two cell-cycle suppressors having a synergistic effect are provided in a pharmaceutical composition.